Sunitinib in the treatment of gastrointestinal stromal tumor: patient selection and perspectives

Sunitinib in the treatment of gastrointestinal stromal tumor: patient selection and perspectives

Nuria Mulet-Margalef, Xavier Garcia-del-Muro Sarcoma Multidisciplinary Unit and Medical Oncology Department, Institut Català d’Oncologia Hospitalet, IDIBELL, Barcelona, Spain Abstract: Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the gastrointe...

Full description

Bibliographic Details
Main Authors: Mulet-Margalef N, Garcia-del-Muro X
Format: Article
Language:English
Published: Dove Medical Press 2016-12-01
Series:OncoTargets and Therapy
Subjects:
Sunitinib
GIST
KIT
refractory GIST
Online Access:https://www.dovepress.com/sunitinib-in-the-treatment-of-gastrointestinal-stromal-tumor-patient-s-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/sunitinib-in-the-treatment-of-gastrointestinal-stromal-tumor-patient-s-peer-reviewed-article-OTT

Similar Items